Healthcare Infection Control Practices Advisory Committee (HICPAC), 22816-22817 [2010-10090]

Download as PDF 22816 Federal Register / Vol. 75, No. 83 / Friday, April 30, 2010 / Notices 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 28, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–10167 Filed 4–29–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meeting wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; NIMH Mentoring Networks to Enhance Diversity. Date: May 25, 2010. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Rebecca Steiner, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6149, MSC 9608, Bethesda, MD 20892–9608, 301–443–4525, steinerr@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; ITVA Conflicts #1. Date: June 1, 2010. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Francois Boller, MD, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6142, MSC 9606, VerDate Mar<15>2010 13:41 Apr 29, 2010 Jkt 220001 Bethesda, MD 20892–9606, 301–443–1513, bollerf@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; ITVA Conflicts #2. Date: June 1, 2010. Time: 4 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Francois Boller, MD, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6142, MSC 9606, Bethesda, MD 20892–9606, 301–443–1513, bollerf@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: April 26, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–10166 Filed 4–29–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Revitalizing Core Environmental Health Programs Through the Environmental Health Specialists Network (EHS-Net) Research (U01), Funding Opportunity Announcement (FOA) EH10–001, Initial Review In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the aforementioned meeting: Times and Dates: 8 a.m.–5 p.m., May 20, 2010 (Closed). 8 a.m.–5 p.m., May 21, 2010 (Closed). Place: JW Marriott Hotel Buckhead, 3300 Lenox Road, Atlanta, GA 30326, Telephone (404) 262–3344. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 response to ‘‘Revitalizing Core Environmental Health Programs through the EHS-Net Research (U01), FOA EH10–001.’’ Agenda items are subject to change as priorities dictate. Contact Person For More Information: J. Felix Rogers, PhD, M.P.H., NCIPC/ERPO, CDC, 4770 Buford Highway, NE., M/S F62, Atlanta, Georgia 30341–3724, Telephone (770) 488–4334. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 26, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–10164 Filed 4–29–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Molecular and Integrative Signal Transduction Study Section, May 25, 2010, 8 a.m. to May 26, 2010, 5:30 p.m., Hotel Palomar, 2121 P Street, NW., Washington, DC 20037 which was published in the Federal Register on April 14, 2010, 75 FR 19408–19409. The meeting will be one day only May 25, 2010, from 8 a.m. to 6:30 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: April 26, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–10148 Filed 4–29–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: E:\FR\FM\30APN1.SGM 30APN1 Federal Register / Vol. 75, No. 83 / Friday, April 30, 2010 / Notices Time and Date: 3:30 p.m.–4:30 p.m., May 17, 2010. Place: Teleconference. Status: Open to the public. The toll free dial in number is (800) 369–2094 and the passcode is 3518331. Teleconference access is limited only by availability of telephone ports. Registration and teleconference logon information is also available at https:// www.cdc.gov/hicpac/. Purpose: The Committee is charged with providing advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), regarding the practice of hospital infection control and strategies for surveillance, prevention, and control of healthcare-associated infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided, including hospitals, ambulatory and long-term care facilities, and home health agencies. The committee shall also advise CDC on periodic updating of existing guidelines, development of new guidelines, guideline evaluation, and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters To Be Discussed: The agenda will include a follow up discussion on the draft Guidelines for the Prevention of Intravascular Catheter-Related Infections. Agenda items are subject to change as priorities dictate. For More Information Contact: Michelle W. King, HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road, NE., Mailstop A–07, Atlanta, Georgia 30333, Telephone: (404) 639–2936, E-mail: HICPAC@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substance and Disease Registry. Dated: April 26, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–10090 Filed 4–29–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1 Food and Drug Administration [Docket No. FDA–2010–N–0001] Emerging Infectious Diseases: Evaluation to Implementation for Transfusion and Transplantation Safety and Quantitative Risk Assessment: Blood Safety and Availability; Public Workshops AGENCY: Food and Drug Administration, HHS. VerDate Mar<15>2010 13:41 Apr 29, 2010 Jkt 220001 22817 registration fee for either public workshop. Early registration is The Food and Drug Administration recommended because seating is (FDA) is announcing two public limited. Registration on the days of the workshops entitled ‘‘Emerging Infectious public workshops will be provided on a Diseases: Evaluation to Implementation space available basis beginning at 7:30 for Transfusion and Transplantation a.m. Safety’’ (EID public workshop) and If you need special accommodations ‘‘Quantitative Risk Assessment: Blood due to a disability, please contact the Safety and Availability’’ (QRA public appropriate contact person (see Contact workshop), respectively. The workshops Person) at least 7 days in advance. have been scheduled on consecutive days to allow interested parties to attend SUPPLEMENTARY INFORMATION: FDA is announcing the following two public both. The EID public workshop is a 2workshops: day workshop; the purpose is to review 1. EID Public Workshop the strategies used for identification, The characterization of risk from, and prioritization, and response to EID that prioritization of response to, emerging are relevant to blood, cells, tissues and organs. The workshop has been planned infectious diseases relevant to blood, cells, tissue and organ safety has always in partnership with the HHS Office of been a complicated process. In terms of Science and Public Health, Centers for preparedness, when multiple EID agents Disease Control and Prevention, National Institutes of Health and Health threaten blood, cells, tissue and organ Resources Services Administration. The safety, it can be a challenge to prioritize efforts to address the resulting risk QRA public workshop is a 1-day related issues since there is no single workshop; the purpose is to review the approach or formula that guarantees an scientific principles of risk assessment ideal prioritization process. The EID and to discuss the role of risk public workshop will address processes assessment in the regulatory process, for early threat detection and risk specifically as it relates to blood safety reduction of EID agents that are relevant and availability. The public workshops to blood, cells, tissues and organs, will feature presentations, case studies including methods of ‘‘horizon and round table discussions led by scanning,’’ risk assessment, risk national and international experts from communication and application of government, academia and industry. emerging pathogen detection and Date and Time: The EID public pathogen reduction technologies. In workshop will be held on May 11 and addition, the workshop will discuss 12, 2010, from 8:00 a.m. to 5:30 p.m., research needed to help address issues each day. The QRA public workshop will be held on May 13, 2010, from 8:30 regarding appropriate screening and testing for donors of human organs, a.m. to 5:00 p.m. Location: Both public workshops will cells, and tissues for transplantation. The first day of the workshop will be held at the Hilton Washington DC focus on transfusion safety and include North/Gaithersburg, 620 Perry Pkwy., discussions on the following topics: (1) Gaithersburg, MD 20877. The identification, surveillance and Contact Person: Persons interested in the EID public workshop should contact prioritization of EID agents in the United States (U.S.) and internationally; Rhonda Dawson, Center for Biologics (2) risk assessment methodologies; and Evaluation and Research (HFM–302), (3) tools to address EIDs, including Food and Drug Administration, 1401 pathogen reduction technologies, Rockville Pike, Suite 550N, Rockville, microarray sequencing and prion MD 20852–1448, 301–827–6129, FAX: detection capabilities. The second day 301–827–2843, e-mail: of the workshop will address organ, cell rhonda.dawson@fda.hhs.gov. and tissue transplantation safety. Topics Persons interested in the QRA public for discussion include the following: (1) workshop should contact Mark O. The regulatory frameworks for cells, Walderhaug, Center for Biologics tissue and organ transplantation; (2) Evaluation and Research (HFM–210), approaches to the identification and Food and Drug Administration, 1401 evaluation of EIDs in the U.S. and Rockville Pike, Suite 400S, Rockville, internationally; (3) risk assessment MD 20852–1448, 301–827–6028, FAX: methodologies; and (4) current research 301–827–0648, e-mail: priorities, limitations and opportunities. mark.walderhaug@fda.hhs.gov. Registration: Mail or fax your 2. QRA Public Workshop registration information (including FDA’s mission to protect public name, title, firm name, address, health is a complex challenge that telephone and fax numbers) to the frequently requires regulators to use appropriate contact person (see Contact sophisticated analyses of risk and Person) by May 5, 2010. There is no benefit to reach informed decisions ACTION: PO 00000 Notice of public workshops. Frm 00082 Fmt 4703 Sfmt 4703 E:\FR\FM\30APN1.SGM 30APN1

Agencies

[Federal Register Volume 75, Number 83 (Friday, April 30, 2010)]
[Notices]
[Pages 22816-22817]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-10090]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:


[[Page 22817]]


    Time and Date: 3:30 p.m.-4:30 p.m., May 17, 2010.
    Place: Teleconference.
    Status: Open to the public. The toll free dial in number is 
(800) 369-2094 and the passcode is 3518331. Teleconference access is 
limited only by availability of telephone ports. Registration and 
teleconference logon information is also available at https://www.cdc.gov/hicpac/.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary, Department of Health and Human Services; 
the Director, CDC; and the Director, National Center for Emerging 
and Zoonotic Infectious Diseases (NCEZID), regarding the practice of 
hospital infection control and strategies for surveillance, 
prevention, and control of healthcare-associated infections (e.g., 
nosocomial infections), antimicrobial resistance, and related events 
in settings where healthcare is provided, including hospitals, 
ambulatory and long-term care facilities, and home health agencies. 
The committee shall also advise CDC on periodic updating of existing 
guidelines, development of new guidelines, guideline evaluation, and 
other policy statements regarding prevention of healthcare-
associated infections and healthcare-related conditions.
    Matters To Be Discussed: The agenda will include a follow up 
discussion on the draft Guidelines for the Prevention of 
Intravascular Catheter-Related Infections.
    Agenda items are subject to change as priorities dictate.
    For More Information Contact: Michelle W. King, HICPAC, Division 
of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road, 
NE., Mailstop A-07, Atlanta, Georgia 30333, Telephone: (404) 639-
2936, E-mail: HICPAC@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substance and 
Disease Registry.

    Dated: April 26, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-10090 Filed 4-29-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.